Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
about
β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2 -Mediated Pathway.Endocannabinoid system in neurodegenerative disorders.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A.Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism.Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K(+) Channel/p38-MAPK Signalling Pathway.Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion.β-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway.Rapid Monitoring of Pharmacological Volatiles of Night-Flowering Evening-Primrose According to Flower Opening or Closing by Fast Gas Chromatography/Surface Acoustic Wave Sensor (Electronic zNose).Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension
P2860
Q37592647-8276C00C-8D31-4BA7-92B1-01A413703829Q39368845-D038CE8E-89BC-4BD1-AC04-015E6E021666Q39392775-3455CED6-A6F0-4573-91EA-3B6F27DBA20EQ47098715-AA6BE242-A8E9-4FEA-A5D0-F4AB45DF6CFAQ47326858-2CC416DF-1F0B-49E7-B32F-73F9CDA5192FQ47694616-1908F818-3CAE-475C-9B26-60546804374EQ48103877-356570C9-2A2F-4693-9B0D-24860390EADFQ48293229-93C9E7D4-DE43-420C-ADCF-8422CF092B45Q48345474-5FCC46D4-E9DF-4FF3-9299-D634FBFC4107Q50648904-54746FC0-4C79-4D0E-B49B-BB22CF362E21Q58696656-290D228A-F4CD-4BD3-8A2B-98865536A1B6
P2860
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@ast
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@nl
type
label
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@ast
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@nl
prefLabel
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@ast
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@nl
P2093
P2860
P921
P3181
P356
P1476
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
P2093
Hayate Javed
M Emdadul Haque
Sheikh Azimullah
Shreesh K Ojha
P2860
P3181
P356
10.3389/FNINS.2016.00321
P407
P577
2016-01-01T00:00:00Z